🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase I/II clinical study to determine the maximum tolerated dose...
Status
Terminated
Location
Research Site
Start Date
2017-07-31
Trial ID
NCT03217838
Treatments Being Tested
This phase I/II trial studies the safety, side effects, and best dose of de...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-09-23
Trial ID
NCT06928662
This phase I/IIa trial studies the side effects and best dose of gene-modif...
Status
Active Not Recruiting
Location
Roswell Park Cancer Institute
Start Date
2017-07-14
Trial ID
NCT02650986
The study is to observe the efficacy and toxicity of demethylating drug dec...
Status
Unknown
Location
Guilin Hospital of Traditional Chinese Medicine
Start Date
2018-02-28
Trial ID
NCT03701451
Treatments Being Tested
This research is being done to assess the therapeutic efficacy and safety o...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology
Start Date
2022-03-01
Trial ID
NCT05177731
Treatments Being Tested
A randomized，multicenter, open-label Phase III, clinical study is conducted...
Status
Recruiting
Location
the First Affiliated Hospital,College of Medicine,Zhejiang University
Start Date
2023-03-03
Trial ID
NCT05586074
Treatments Being Tested
Evaluate the safety and efficacy of oral azacitidne (CC-486) twice daily (B...
Status
Completed
Location
Local Institution - 113
Start Date
2015-07-06
Trial ID
NCT02281084
Treatments Being Tested
This phase Ib trial is to find the side effect and best dose of navitoclax ...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2022-07-29
Trial ID
NCT05222984
Treatments Being Tested
The purpose of this study is to investigate the overall response rate (ORR)...
Status
Completed
Location
Multiple Locations
Start Date
2010-12
Trial ID
NCT01400633
Treatments Being Tested
This phase I trial studies the side effects and the best dose of cytarabine...
Status
Completed
Location
Ohio State University Comprehensive Cancer Center
Start Date
2010-05-17
Trial ID
NCT01130506
Treatments Being Tested